Corpovael SAB Valuation
| CADUA Stock | MXN 3.50 0.00 0.00% |
At this time, the firm appears to be fairly valued. Corpovael SAB de shows a prevailing Real Value of 3.49 per share. The current price of the firm is 3.5. Our model approximates the value of Corpovael SAB de from analyzing the firm fundamentals such as Profit Margin of (0.07) %, current valuation of 3.75 B, and Return On Equity of -0.0388 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Corpovael SAB's price fluctuation is slightly risky at this time. Calculation of the real value of Corpovael SAB de is based on 3 months time horizon. Increasing Corpovael SAB's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Corpovael stock is determined by what a typical buyer is willing to pay for full or partial control of Corpovael SAB de. Since Corpovael SAB is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Corpovael Stock. However, Corpovael SAB's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.5 | Real 3.49 | Hype 3.5 |
The intrinsic value of Corpovael SAB's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Corpovael SAB's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Corpovael SAB de helps investors to forecast how Corpovael stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Corpovael SAB more accurately as focusing exclusively on Corpovael SAB's fundamentals will not take into account other important factors: Corpovael SAB Total Value Analysis
Corpovael SAB de is currently expected to have takeover price of 3.75 B with market capitalization of 931.98 M, debt of 1.97 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Corpovael SAB fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.75 B | 931.98 M | 1.97 B |
Corpovael SAB Investor Information
About 68.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.17. Some equities with similar Price to Book (P/B) outperform the market in the long run. Corpovael SAB de last dividend was issued on the 26th of September 2019. Based on the measurements of operating efficiency obtained from Corpovael SAB's historical financial statements, Corpovael SAB de is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Corpovael SAB Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Corpovael suggests not a very effective usage of assets in November.Corpovael SAB Ownership Allocation
Corpovael SAB holds a total of 319.17 Million outstanding shares. Corpovael SAB de shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 67.7 percent of Corpovael SAB de outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Corpovael SAB Profitability Analysis
The company reported the revenue of 2.78 B. Net Loss for the year was (103.64 M) with profit before overhead, payroll, taxes, and interest of 684.78 M.About Corpovael SAB Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Corpovael SAB de. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Corpovael SAB de based exclusively on its fundamental and basic technical indicators. By analyzing Corpovael SAB's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Corpovael SAB's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Corpovael SAB. We calculate exposure to Corpovael SAB's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Corpovael SAB's related companies.8 Steps to conduct Corpovael SAB's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Corpovael SAB's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Corpovael SAB's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Corpovael SAB's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Corpovael SAB's revenue streams: Identify Corpovael SAB's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Corpovael SAB's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Corpovael SAB's growth potential: Evaluate Corpovael SAB's management, business model, and growth potential.
- Determine Corpovael SAB's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Corpovael SAB's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in Corpovael Stock
Corpovael SAB financial ratios help investors to determine whether Corpovael Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Corpovael with respect to the benefits of owning Corpovael SAB security.